ncRNA name
hsa-miR-218
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
SMO
Cancer name
Gastric Cancer
Cancer site
Stomach
Treatment type
Chemotherapy
Drug
Adriamycin/Oxaliplatin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
These findings suggest that miR-218 inhibits MDR of gastric cancer cells by down-regulating SMO expression.
Tissue resource
human gastric adenocarcinoma cell lines SGC7901
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Guangzhou Medical University
Country
China
Continent
Asia